However, in stark contrast to WT mice, where we observed a proportion of mice failing to develop a palpable tumor, all RAGo/o mice that were challenged with either B16_IFNα2 or B16_IFNα9 developed palpable tumors (Figure 3B). This evidence concerns the gene IFNA2 and neoplasm.